UBS Group Has Lowered Expectations for Celsius (NASDAQ:CELH) Stock Price

Celsius (NASDAQ:CELHFree Report) had its price target trimmed by UBS Group from $50.00 to $45.00 in a report published on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.

CELH has been the topic of a number of other reports. Jefferies Financial Group lowered their target price on shares of Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. Stifel Nicolaus dropped their price objective on Celsius from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Thursday, September 5th. Morgan Stanley restated an “equal weight” rating and set a $50.00 target price on shares of Celsius in a research note on Tuesday, August 20th. TD Cowen dropped their price target on Celsius from $68.00 to $50.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Finally, Maxim Group reduced their price objective on Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, September 5th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, Celsius presently has an average rating of “Moderate Buy” and a consensus target price of $54.40.

View Our Latest Stock Report on Celsius

Celsius Stock Down 3.7 %

Shares of Celsius stock opened at $28.90 on Thursday. Celsius has a 12-month low of $27.78 and a 12-month high of $99.62. The stock has a market capitalization of $6.79 billion, a P/E ratio of 40.14, a PEG ratio of 2.51 and a beta of 1.86. The stock has a 50 day moving average price of $32.15 and a two-hundred day moving average price of $51.06.

Insider Activity

In other news, CEO John Fieldly sold 74,847 shares of Celsius stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the sale, the chief executive officer now directly owns 1,812,490 shares in the company, valued at approximately $59,449,672. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Celsius

Several hedge funds and other institutional investors have recently modified their holdings of CELH. Mirae Asset Global Investments Co. Ltd. raised its stake in Celsius by 19.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 64,515 shares of the company’s stock worth $5,563,000 after acquiring an additional 10,634 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in Celsius by 142.2% during the 1st quarter. Janney Montgomery Scott LLC now owns 26,090 shares of the company’s stock valued at $2,163,000 after purchasing an additional 15,316 shares during the last quarter. Nordea Investment Management AB boosted its position in Celsius by 41.9% in the first quarter. Nordea Investment Management AB now owns 11,550 shares of the company’s stock valued at $962,000 after buying an additional 3,412 shares in the last quarter. Csenge Advisory Group grew its stake in Celsius by 8.9% during the first quarter. Csenge Advisory Group now owns 5,583 shares of the company’s stock worth $463,000 after buying an additional 454 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Celsius by 2,956.9% during the first quarter. Geneos Wealth Management Inc. now owns 1,773 shares of the company’s stock worth $147,000 after buying an additional 1,715 shares in the last quarter. Institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Recommended Stories

Analyst Recommendations for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.